183 related articles for article (PubMed ID: 12079302)
1. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia.
Horowitz N; Pinto K; Mutch DG; Herzog TJ; Rader JS; Gibb R; Bocker-Edmonston T; Goodfellow PJ
Gynecol Oncol; 2002 Jul; 86(1):62-8. PubMed ID: 12079302
[TBL] [Abstract][Full Text] [Related]
2. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.
Simpkins SB; Bocker T; Swisher EM; Mutch DG; Gersell DJ; Kovatich AJ; Palazzo JP; Fishel R; Goodfellow PJ
Hum Mol Genet; 1999 Apr; 8(4):661-6. PubMed ID: 10072435
[TBL] [Abstract][Full Text] [Related]
3. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
4. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M
Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161
[TBL] [Abstract][Full Text] [Related]
5. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
[TBL] [Abstract][Full Text] [Related]
6. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
[TBL] [Abstract][Full Text] [Related]
7. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma.
Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042
[TBL] [Abstract][Full Text] [Related]
9. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG
Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and immunohistochemical analysis of MLH1 and MSH2 in normal endometrium, endometrial hyperplasia and endometrial cancer from a hereditary nonpolyposis colorectal cancer patient.
Ichikawa Y; Tsunoda H; Takano K; Oki A; Yoshikawa H
Jpn J Clin Oncol; 2002 Mar; 32(3):110-2. PubMed ID: 11956307
[TBL] [Abstract][Full Text] [Related]
11. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
12. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.
Esteller M; Catasus L; Matias-Guiu X; Mutter GL; Prat J; Baylin SB; Herman JG
Am J Pathol; 1999 Nov; 155(5):1767-72. PubMed ID: 10550333
[TBL] [Abstract][Full Text] [Related]
13. Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur.
Cohn DE; Mutch DG; Herzog TJ; Rader JS; Dintzis SM; Gersell DJ; Todd CR; Goodfellow PJ
Genes Chromosomes Cancer; 2001 Dec; 32(4):295-301. PubMed ID: 11746970
[TBL] [Abstract][Full Text] [Related]
14. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
Zighelboim I; Goodfellow PJ; Gao F; Gibb RK; Powell MA; Rader JS; Mutch DG
J Clin Oncol; 2007 May; 25(15):2042-8. PubMed ID: 17513808
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
[TBL] [Abstract][Full Text] [Related]
17. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
Hardisson D; Moreno-Bueno G; Sánchez L; Sarrió D; Suárez A; Calero F; Palacios J
Mod Pathol; 2003 Nov; 16(11):1148-58. PubMed ID: 14614055
[TBL] [Abstract][Full Text] [Related]
19. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
[TBL] [Abstract][Full Text] [Related]
20. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H
J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]